Pages that link to "Q34720299"

The following pages link to Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition (Q34720299):

Displaying 41 items.

• Antitussives and substance abuse (Q26866183) (← links)
• Acute psychosis with Coricidin cold medicine (Q28188633) (← links)
• Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability (Q31044030) (← links)
• Summary of information on human CYP enzymes: human P450 metabolism data (Q32103802) (← links)
• Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect (Q33838839) (← links)
• Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects (Q34177818) (← links)
• An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan (Q34259684) (← links)
• The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence. (Q34612112) (← links)
• Modulation of CYP2D6 and CYP3A4 metabolic activities by Ferula asafetida resin (Q34800242) (← links)
• Computational predictions of the site of metabolism of cytochrome P450 2D6 substrates: comparative analysis, molecular docking, bioactivation and toxicological implications (Q35646205) (← links)
• Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions (Q36851934) (← links)
• Dextromethorphan/quinidine: in pseudobulbar affect (Q37863094) (← links)
• Analysis of Dextromethorphan and Dextrorphan in Skeletal Remains Following Differential Microclimate Exposure: Comparison of Acute vs. Repeated Drug Exposure (Q38613925) (← links)
• A case of acute psychosis secondary to coricidin overdose (Q38634508) (← links)
• AVP-786 for the treatment of agitation in dementia of the Alzheimer's type (Q39034436) (← links)
• Dextromethorphan inhibition of voltage-gated proton currents in BV2 microglial cells (Q39367396) (← links)
• Pharmacokinetics of dextromethorphan and its metabolites in horses following a single oral administration (Q39435571) (← links)
• Dextromethorphan improves levodopa-induced dyskinesias in Parkinson's disease (Q42540896) (← links)
• Pharmacokinetic profile of dextromethorphan hydrobromide in a syrup formulation in children and adolescents (Q42672227) (← links)
• Effect of metabolic blockade on the psychoactive effects of dextromethorphan (Q43205099) (← links)
• Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe (Q43576840) (← links)
• Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorpan HBr. (Q43613498) (← links)
• The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein (Q44048901) (← links)
• The molecular and enzyme kinetic basis for the diminished activity of the cytochrome P450 2D6.17 (CYP2D6.17) variant. Potential implications for CYP2D6 phenotyping studies and the clinical use of CYP2D6 substrate drugs in some African populations (Q44188968) (← links)
• Effect of terbinafine on the pharmacokinetics and pharmacodynamics of desipramine in healthy volunteers identified as cytochrome P450 2D6 (CYP2D6) extensive metabolizers. (Q44202468) (← links)
• Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers (Q45040972) (← links)
• Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection (Q45356395) (← links)
• Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease (Q46280394) (← links)
• Systemic dextromethorphan and dextrorphan are less toxic in rats than bupivacaine at equianesthetic doses (Q48314853) (← links)
• Development of the "Inje cocktail" for high-throughput evaluation of five human cytochrome P450 isoforms in vivo (Q48610657) (← links)
• Dextromethorphan-induced psychotoxic behaviors cause sexual dysfunction in male mice via stimulation of σ-1 receptors (Q48664292) (← links)
• Dextromethorphan Abuse Leading to Assault, Suicide, or Homicide (Q48691370) (← links)
• Mechanisms of Nicotinic Modulation of Glutamatergic Neuroplasticity in Humans (Q52147631) (← links)
• Dextromethorphan Abuse and Dependence in Adolescents (Q57380873) (← links)
• A rapid and simple LC–MS/MS method for the simultaneous evaluation of CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 hydroxylation capacity (Q57585643) (← links)
• Cytochrome P4502D6(CYP2D6) Bioelectrode for Fluoxetine (Q58305924) (← links)
• Randomized Open-Label Drug-Drug Interaction Trial of Dextromethorphan/Quinidine and Paroxetine in Healthy Volunteers (Q86388268) (← links)
• Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition (Q60061950) (← links)
• Simultaneous determination of dextromethorphan and its metabolites in human plasma by capillary electrophoresis (Q77909313) (← links)
• Inter-individual Variability of In Vivo CYP2D6 Activity in Different Genotypes (Q83325564) (← links)
• Effect of Curcuma longa on CYP2D6- and CYP3A4-mediated metabolism of dextromethorphan in human liver microsomes and healthy human subjects (Q87258926) (← links)